Dow Chemical announced it will sell the majority of its century-old chlorine business. Here's why the company's vision for the future is likely to pay off for investors.
The journal that published a woefully bad study claiming that GMO corn causes cancer is retracting it, after a year-long investigation. The lead author is protesting and threatening to sue. It's a terrible study that never should have been published, but is the journal right to retract it?
Though votes to require labeling of GM food have lost, there's clearly significant interest on the part of grocery shoppers.
The infamous and controversial Seralini study that appeard to show how consuming Monsanto products would lead to an increased risk of developing cancerous tumors, as shown in rats, has been retracted. Will that change the way you view potential health risks associated with GMO foods?
While some options might require a little extra cash, it doesn't always hurt the wallet to buy non-GMO fare.
Mosaic, Deere, and Monsanto are readying themselves for booming global food demand in the years ahead. Here's why they can meet investors' hunger for growth and income.
The Dow and S&P 500 extended their losing streak into a fourth successive day as strong private sector labor data intensified apprehensions that the Federal Reserve would soon begin trimming its economic stimulus package
I am going to jump right into the technology story on Monsanto and that's basically geared on how we increase yield and productivity and what I want to emphasize today is a lot of the growth platforms, some of the new technologies, some of the new global opportunities we see for growth and basically point that all of the innovations that I think are going to drive our lead and as a technology company and with more commercial product to our pipeline, so as always from an R&D perspective I am going to be forward-looking and you all know what that mean. At our November Investor Day, we talked about where yields were.
Signs of a weak holiday shopping season and apprehensions over the central bank trimming its economic stimulus plan dragged benchmarks into the red on Tuesday
Monsanto Company was a leading decliner within the chemicals industry, falling $1.71 (-1.5%) to $111.58 on light volume
Can this agri-giant's domination of the flour-mill industry withstand regulatory scrutiny?
TheStreet highlights 5 stocks pushing the basic materials sector lower today.
Looking at setups in Monsanto and Agrium.
Opponents of genetically modified food suffer a setback.
The country watched as voters in Washington weighed in on whether or not to enact GMO labeling laws affecting several food products in the state. However, Connecticut and Maine passed similar legislation back in June. Can a built-in compromise succeed in establishing the nation's first GMO labeling law?